Basel Healthtech fund successfully closed
The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first funds to invest in innovative European Healthtech firms in the growth phase.
Christoph Kausch, Managing Partner and Co-Founder of MTIP (img: MTIP)
MTIP has completed the fundraising phase for its second fund. As the Basel-based private equity firm announced on December 7, it raised a total of 250 million US dollars in capital commitments under its MTIP Fund II instead of the original target of 225 million US dollars.
The “dark green”, sustainability-focused fund is one of the first of its kind to specialize in the Healthtech sector. It invests in digital health companies and digitally-connected medical technology firms with the aim of supporting international expansion plans. “We are excited to announce the successful closing of our second fund and continue our mission to build the Healthtech leaders of tomorrow”, explains Christoph Kausch, Managing Partner at MTIP, in the press release.
New and existing investors in the fund included institutional investors, pension funds, family offices, hospitals, foundations and the health insurance firm Sanitas, further details of which can be found in the press release. Andreas Schönenberger, CEO of Sanitas, praised MTIP’s “unique expertise in Healthtech” that allows it to foster innovation “in this under-served private equity sector”.
Share this article
You may also be interested in
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...Read More